Navigation Links
Perrigo Company to Present at the Goldman Sachs 32nd Annual Global Health Care Conference
Date:6/3/2011

ALLEGAN, Mich., June 3, 2011 /PRNewswire/ -- Perrigo Company (Nasdaq: PRGO;TASE) today announced that Perrigo Chairman and CEO Joseph C. Papa will present at the Goldman Sachs 32nd Annual Global Health Care Conference on Thursday, June 9th, 2011 at 10:30 AM (PT) at the Terranea Resort in Rancho Palos Verdes, CA.  

Perrigo Company is a leading global healthcare supplier that develops, manufactures and distributes OTC and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products and active pharmaceutical ingredients (API).  The Company is the world's largest store brand manufacturer of OTC pharmaceutical products and infant formulas. The Company's primary markets and locations of manufacturing and logistics operations are the United States, Israel, Mexico, the United Kingdom and Australia. Visit Perrigo on the Internet (http://www.perrigo.com). 


'/>"/>
SOURCE Perrigo Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Perrigos Partner Synthon Receives FDA Tentative Approval for Levocetirizine Solution - Generic Equivalent to Xyzal® Oral Solution
2. Perrigo Announces FDA Final Approval for Ranitidine 150 - Generic Equivalent to Zantac 150®
3. Perrigo Announces Settlement of Cutivate Lotion Litigation
4. Perrigo to Introduce New Dosing System and Labeling for Certain Pediatric Pain Relievers
5. Perrigo Reports Record Quarterly Revenue and Earnings and Raises Full Year Adjusted EPS Guidance
6. Perrigo Announces FDA Final Approval for Minoxidil Foam - Generic Equivalent to Mens Rogaine® Foam
7. Perrigo Company Announces Quarterly Dividend
8. Perrigos PBM Infant Formula Unit Wins Appellate Judgment Versus Mead Johnson
9. Perrigo Partner Teva Receives Final OTC Approval for Sales and Distribution of Fexofenadine HCl 60 mg and 180 mg Tablets
10. Perrigo Announces Conclusion of the FDA Re-Inspection
11. Perrigo Company to Present at the Barclays Capital 2011 Global Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... Utah , Aug. 28, 2015  Today, in ... Prevention,s (CDC) Contact Lens Health Week, 1-800 Contacts is ... has found that contact lens wearers who do not ... greatest risk for eye infections. Most ... their lenses, but a clean lens case is sometimes ...
(Date:8/28/2015)... , Aug. 28, 2015 ... the addition of the "Investigation Report on China,s ... Developed by Novartis, ranibizumab was approved by CFDA ... 2012. Currently, only Lucentis, a product of Novartis, is ... as the first self- developed drug for the treatment ...
(Date:8/28/2015)... Denmark and ATLANTA ... 31, 2015 the US Food and Drug Administration (FDA) cleared ... Depressive Disorder in adult patients who have failed to receive ... TMS is a non-invasive technique for stimulating neural tissue in ... Major Depressive Disorder. The procedure has been proven safe and ...
Breaking Medicine Technology:1-800 Contacts Shares Tips on How to Clean Lens Cases 2Investigation Report on China's Ranibizumab Market, 2012-2019 2Therapy System for Treating Major Depressive Disorder Receives FDA Clearance 2Therapy System for Treating Major Depressive Disorder Receives FDA Clearance 3
... Inc. (NASDAQ: STXS ) announced today ... collaboration with Biosense Webster, Inc. related to Stereotaxis, ... broadest and most committed cooperative agreement around Odyssey ... Stereotaxis has granted Biosense Webster global, non-exclusive rights ...
... Calif., May 5, 2011 NeurogesX, Inc. (NASDAQ: ... novel pain management therapies, announced today that Anthony DiTonno, President ... 10th Annual JMP Securities Research Conference, to be held May ... Annual JMP Securities Research Conference Date : , Monday, ...
Cached Medicine Technology:Stereotaxis and Biosense Webster Announce New Strategic Collaboration 2Stereotaxis and Biosense Webster Announce New Strategic Collaboration 3Stereotaxis and Biosense Webster Announce New Strategic Collaboration 4NeurogesX to Present at 10th Annual JMP Securities Research Conference 2NeurogesX to Present at 10th Annual JMP Securities Research Conference 3
(Date:8/28/2015)... ... August 29, 2015 , ... Rio Salado College ... and the student experience as part of the EDUCAUSE - Next Generation Learning Challenges ... , This is the third Breakthrough Models Incubator hosted by EDUCAUSE and ...
(Date:8/28/2015)... , ... August 28, 2015 , ... ... Malaria Day at the Zoo to celebrate children helping children, a thank you ... congregations throughout West Ohio have contributed to the United Methodist initiative to end ...
(Date:8/28/2015)... ... ... With the goal of furthering music education programs in schools, the “Music ... Fairgrounds in Mendon, IL on May 30th, 2015. Backed once again by Best Drug ... underfunded school districts of Mendon and its neighboring town of Quincy, IL. Best Drug ...
(Date:8/28/2015)... ... August 28, 2015 , ... As reported by Medical Daily on August ... for results that last for two years, the longest of any cellulite reduction system ... looking for a long-lasting, effective solution for their cellulite, according to Dr. Robert Weiss, ...
(Date:8/28/2015)... ... August 28, 2015 , ... Loved ones of a person ... with chemical dependency, may be able to find some hope in the latest ... center for addiction located in Western Michigan. Focusing on several different aspects of ...
Breaking Medicine News(10 mins):Health News:Rio Salado College Joins 9 Educational Leaders to Reinvent Higher Learning 2Health News:Rio Salado College Joins 9 Educational Leaders to Reinvent Higher Learning 3Health News:Rio Salado College Joins 9 Educational Leaders to Reinvent Higher Learning 4Health News:Saturday’s United Methodist Event at Columbus Zoo Celebrates Imagine No Malaria 2Health News:Saturday’s United Methodist Event at Columbus Zoo Celebrates Imagine No Malaria 3Health News:Best Drug Rehabilitation Interviews Country-Rock Duo Highway Run at the 2015 "Music With A Mission" Benefit Concert 2Health News:Maryland Dermatologists Discuss Non-Invasive Cellulite Reduction System Cellfina Receiving 2-Year FDA Clearance 2Health News:Maryland Dermatologists Discuss Non-Invasive Cellulite Reduction System Cellfina Receiving 2-Year FDA Clearance 3Health News:Best Drug Rehabilitation Releases New Video Outlining Patients' Personal Recovery Stories 2Health News:Best Drug Rehabilitation Releases New Video Outlining Patients' Personal Recovery Stories 3
... LigoCyte Pharmaceuticals, Inc. announced today that its ... and related gastrointestinal illness collectively known as acute ... "the stomach flu" is one of the most ... and diarrhea afflicting 21 million Americans annually and ...
... -- Hispanic women have a 20 percent greater risk ... according to a new study. Biological differences in ... suggested. "This difference may be associated with a ... Baumgartner, an epidemiology professor at the School of Public ...
... By Mary Brophy Marcus HealthDay Reporter , WEDNESDAY, ... the outer layer of the brain and work its way ... upends long-held beliefs about the nervous system disease. The ... is diagnosed and treated, appear to solidify a theory that,s ...
... and the identification of sensitive biomarkers for early detection and/or ... New work published in the Dec. 7 issue of the ... the development of blood-based DNA markers for ovarian cancer. ... of Southern California in Los Angeles, found that a DNA ...
... Gardner HealthDay Reporter , WEDNESDAY, Dec. 7 ... appears to boost survival in women with certain types ... These preliminary findings regarding the bone-building drug zoledronic acid ... their tumors. The studies are slated for presentation at ...
... By Steven Reinberg HealthDay Reporter , ... are screened for and diagnosed with low-risk prostate cancer, ... National Institutes of Health panel concluded that research on ... prostate cancer is discovered, many men opt for surgery ...
Cached Medicine News:Health News:NEJM publishes study showing LigoCyte's norovirus vaccine demonstrates protection against illness 2Health News:NEJM publishes study showing LigoCyte's norovirus vaccine demonstrates protection against illness 3Health News:NEJM publishes study showing LigoCyte's norovirus vaccine demonstrates protection against illness 4Health News:Hispanic Women More Likely to Die of Breast Cancer 2Health News:MS May Take a Different Pathway Than Previously Thought 2Health News:MS May Take a Different Pathway Than Previously Thought 3Health News:Bone Drugs May Also Battle Breast Cancer, Researchers Say 2Health News:Active Surveillance May Benefit Men With Low-Risk Prostate Cancer 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: